Tag: cbd
-
FDA Warns CBD Sellers for COVID-19 Claims
The U.S. Food and Drug Administration has urged several sellers of products with cannabidiol (CBD) to stop marketing their products as able to treat or prevent COVID-19. The letters, sent by the Center for Drug Evaluation and Research (CDER), emphasize that “FDA is taking urgent measures to protect consumers from certain products that, without approval…
-
FDA Issues Warning Letters, Consumer Update on CBD, Sparking Litigation Against CBD Cos.
The U.S. Food and Drug Administration (FDA) has issued a consumer update on cannabidiol (CBD) products and other products containing ingredients derived from cannabis. The update clarified that FDA “is concerned that people may mistakenly believe that trying CBD ‘can’t hurt’” because the agency has “seen only limited data about CBD’s safety and these data…
-
USDA Receives Hundreds of Comments on Hemp Interim Rule
Two weeks after opening a comment period on an interim final rule on hemp farming, the U.S. Department of Agriculture (USDA) has received more than 600 comments. The rule set limits for the amount of tetrahydrocannabinol (THC) that can legally be produced by the crop, and farmers have reportedly told the agency that the limit…
-
FDA, FTC Warn CBD Company for Unsubstantiated Claims
The U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have announced a joint warning letter sent to Rooted Apothecary LLC focused on the potential benefits that the company claimed its cannabidiol (CBD) products could provide. “The Agency continues to be concerned about the proliferation of products asserting to contain CBD that are…
-
FDA Warns Company Selling CBD Oil
The U.S. Food and Drug Administration has published a warning letter it sent in September 2019 to a company selling cannabidiol (CBD) oil as a dietary supplement. “This product is labeled as a dietary supplement; however, it cannot be a dietary supplement because it does not meet the definition of a dietary supplement,” the letter…
-
House Passes Cannabis Banking Bill
The U.S. House of Representatives has passed the SAFE Banking Act, which allows financial-service firms to work with “cannabis-related legitimate businesses and service providers,” providing protection from federal prosecution for banks in states that have legalized cannabis. The bill, introduced by Rep. Ed Perlmutter (D-Colo.), has been sent to the Senate. In its press release…
-
Company Misleads on CBD Content, Consumer Alleges
A consumer has filed a putative class action alleging that the labels of Global Widget’s products containing cannabidiol (CBD), including gummies, lollipops and syrup, do not identify an accurate amount of CBD in the products. Ahumada v. Global Widget LLC, No. 12005 (D. Mass., filed September 24, 2019). “Defendant makes numerous false and misleading claims…
-
Proposed Amendment Would Provide Funds for FDA Oversight of CBD
Rep. Jerry McNerney (D-Calif.), in partnership with the Natural Products Association, has reportedly filed an amendment to the House Agriculture appropriations bill that would give the U.S. Food and Drug Administration (FDA) funding to undertake the process to identify a safe daily intake level of cannabidiol (CBD). “Since the passage of the 2018 Farm Act…